HIV-1疫苗与HIV/AIDS

[1] Potent CD4+ T cell responses elicited by a bicistronic HIV- 1 DNA vaccine expressing gp120 and GM-CSF. Barouch DH,Santra S,Tenner-Racz K,et al. J Immunol . 2002

[2] Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL. Belyakov IM,Ahlers JD,Clements JD,et al. J Immunol . 2000

[3] Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. Moore AC,Kong WP,Chakrabarti BK,et al. Journal of Virology . 2002

[4] A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Toledo H,Baly A,Castro O,et al. Vaccine . 2001

[5] AIDS [J]. 2001, American Chemical Society (79)

[6] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Amara RR. Villinger F,Altman JD,et al. Science . 2001

[7] Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. Kaslow RA,Rivers C,Tang J,et al. Journal of Virology . 2001

[8] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Barouch DH,Santra S,Schmitz JE,et al. Science . 2000

[9] Potentiation of simian immunodeficiency virus (SIV)-specific CD4 (+ ) and CD8 (+ ) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. Hel Z,Tsai WP,Thornton A,et al. J Immunol . 2001

[10] Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells. Zhong W,Roberts AD,Woodland DL. J Immunol . 2001

[1] Potent CD4+ T cell responses elicited by a bicistronic HIV- 1 DNA vaccine expressing gp120 and GM-CSF. Barouch DH,Santra S,Tenner-Racz K,et al. J Immunol . 2002

[2] Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL. Belyakov IM,Ahlers JD,Clements JD,et al. J Immunol . 2000

[3] Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. Moore AC,Kong WP,Chakrabarti BK,et al. Journal of Virology . 2002

[4] A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Toledo H,Baly A,Castro O,et al. Vaccine . 2001

[5] AIDS [J]. 2001, American Chemical Society (79)

[6] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Amara RR. Villinger F,Altman JD,et al. Science . 2001

[7] Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. Kaslow RA,Rivers C,Tang J,et al. Journal of Virology . 2001

[8] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Barouch DH,Santra S,Schmitz JE,et al. Science . 2000

[9] Potentiation of simian immunodeficiency virus (SIV)-specific CD4 (+ ) and CD8 (+ ) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. Hel Z,Tsai WP,Thornton A,et al. J Immunol . 2001

[10] Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells. Zhong W,Roberts AD,Woodland DL. J Immunol . 2001